dopamin muscarin cholinerg receptor densiti caudat specimen parkinsonian patient bind spiperon benzil qnb hydrogen caudat tissu parkinsonian patient time cerebr transplant homogen group patient respons mark disabl secondari clinic fluctuat short-dur respons medication-induc dyskinesia substanti dose levodopa patient bromocriptin pergolid bind densiti dopamin receptor spiperon bind group patient specimen autopsi control find medication-induc receptor downregul parallel chang muscarin cholinerg receptor qnb bind control valu reduct muscarin receptor due loss nigrostriat termin muscarin receptor muscarin receptor increas corticostriat glutamaterg input cell present promin levodopa-induc dyskinesia receptor deficit reflect widespread degen cerebr diseas levodopa-refractori symptom patient 